Synthesis of some pentanuclear platinum clusters [Pt5(CO)6(L)4]. The X-ray structure of [Pt5(μ-CO)5(CO)(PCy3)4]

[Pt₅(μ-CO)₅(CO)L₄] (L = PPh₃1, PPh₂Bz 2, AsPh₃3, PEt₃4, PCy₃5) have been synthesized by reacting [Pt₃(μ-CO)₃(PR₃)₃] with H₂O₂ (1 and 2), by reduction of cis-[PtCl₂(CO)(PEt₃)] with Zn dust (4), and by the Zn reduction of [Pt₃(μ-CO)₃(PCy₃)₃] in the presence of [PtCl₂(CH₃CN)₂] (5). Complex 5 has not been observed previously and has been characterized by X-ray crystallography. Oxidation of the phosphine ligands with H₂O₂ is a new way to synthesize 1 and 2. The first complete NMR characterization of these complexes has also been achieved, and showed that these pentanuclear cluster complexes exhibit similar stereochemistries in solution and in the solid state. The observed ¹J_Pt-Pt values do not have any correlation with the corresponding bond lengths, again pointing out the irregular behaviour of such parameter in Pt complexes.     

Evidence for 6-keto-PGF1α in adrenal cortex of the rat and effects of 6-keto-PGF1α and PGI2 on adrenal cAMP levels and steroidogenesis

Both intact cortical tissue and isolated cortical cells from the adrenal gland of the rat were analyzed for 6-keto-PGF_1α, the hydrolysis metabolite of PGI₂, using high-performance liquid chromatography and gas chromatography-mass spectrometry. 6-Keto-PGF_1α was present in both incubations of intact tissue and isolated cells of the adrenal cortex, at higher concentrations than either PGF_2α or PGE₂. Thus, the cortex does not depend upon vascular components for the synthesis of the PGI₂ metabolite. Studies $\text{in vitro}$, using isolated cortical cells exposed to 6-keto-PGF_1α (10^?6-10^?4M), show that this PG does not alter cAMP levels or steroidogenesis. Cells exposed to PGI₂ (10^?6-10^?4M), however, show a concentration-dependent increase of up to 4-fold in the levels of cAMP without altering corticosterone production. ACTH (5–200 μU/ml) increased cAMP levels up to 14-fold, and corticosterone levels up to 6-fold, in isolated cells. ACTH plus PGI₂ produced an additive increase in levels of cAMP, however, the steroidogenic response was equal to that elicited by ACTH alone. Adrenal glands of the rat perfused $\text{in situ}$ with PGI₂ showed a small decrease in corticosterone production, whereas ACTH greatly stimulated steroid release. Thus, while 6-keto-PGF_1α is present in the rat adrenal cortex, its precursor, PGI₂, is not a steroidogenic agent in this tissue although it does stimulate the accumulation of cAMP.     

Photochemical displacement of the benzene ligand in [(η-C6H6)Ru(CH3CN)2(L)] and [(η-C6H6)Ru(CH3CN)(L2)] (L=CH3CN, PPh3, L2=dppe, bipy)

Photoirradiation with a 150 W medium-pressure Hg lamp for 17 h in acetontrile as the solvent replaces the benzene ligand in the cationic complexes [(η⁶-C₆H₆)Ru(CH₃CN)₂(L)]²⁺ and [(η⁶-C₆H₆)Ru(CH₃CN)(L₂)]²⁺ (L=CH₃CN, PPh₃, L₂=dppe, bipy) with acetonitrile. These replacements are equally clean to those reported before for analogous CpRu⁺ complexes. Crystal structures of the products obtained are included.     

Octahedral (cyclopentadienyl)rhodium clusters [Rh6Cp6(μ6-C)] and [Rh6Cp6(μ3-CO)2]: Synthesis, structures and electrochemistry

The 86-electron dicationic octahedral rhodium clusters containing Cp (Cp = C₅H₅) ligands and either an interstitial carbon atom, [Rh₆Cp₆(μ₆-C)]²⁺ ([1]²⁺), or two carbonyl groups, [Rh₆Cp₆(μ₃-CO)₂]²⁺ ([2]²⁺), were synthesized in low yields by reactions of Rh₃Cp₃(μ-CO)₃ with RhCp(C₂H₄)₂ or [RuCp^∗(MeCN)₃]⁺ (Cp^∗ = C₅Me₅), respectively. The structures of [1]²⁺ and [2]²⁺ were determined by X-ray diffraction. Their electrochemical behavior proved that they possess a rather extended electron transfer activity. In accordance with DFT calculations, the nearly octahedral structure of [1]²⁺ and [2]²⁺ is retained both upon oxidation (2+/3+) and the first reduction (2+/+); however, the second reduction (+/0) results in the breaking of one (for [1]⁰) or two (for [2]⁰) Rh-Rh bonds. In the case of the related Dahl’s nickel cluster Ni₆Cp₆ the nearly octahedral structure is retained upon all redox steps (3+/2+/+/0/−/2−).     

Comparison of the effects of prostaglandins D2, F2α and E1 on spontaneous contractions of rabbit oviduct

The effects of PGD₂, PGF_2α and PGE₁ were studied on the circular muscle of post-ovulatory rabbit oviducts $\text{in vitro}$. PGE₁ inhibited spontaneous contractile activity. Lower concentrations of PGD₂ and PGF_2α were stimulatory and higher concentrations were inhibitory. Since PGD₂ may be produced in the oviduct, any hypothesis concerning the role of prostaglandins in the control of oviductal motility and ovum transport should include PGD₂ as well as PGFs and PGEs.     

Ethanol catalyzed synthesis of titanocene aryl carboxylate complexes and crystal structure of (η-C5H5)2Ti(2-OH-5-S-O2CC6H3)2

A method for the synthesis of titanocene (IV) aryl carboxylate complexes is presented in this paper. It is based on the fact that alcohol can catalyze the reaction between Cp₂TiCl₂ and aryl carboxylate ligands in the presence of sodium hydroxide (NaOH). The effects of the catalyst on the reaction system were studied and the possible reaction mechanism was proposed. This method was used to prepare a series of titanocene (IV) aryl carboxylate complexes and a macrocyclic titanocene (5,5′-dithiodisalicylato titanocene), whose structure was determined by X-ray diffraction analysis.     

Formation of 6-oxoprostaglandin F1α by arteries of the fetal calf

Homogenates from fetal calf aorta converted arachidonic acid to two main products which were shown by gas chromatography-mass spectrometry to be different forms of 6-oxoprostaglandin F_1α. Aortas from fetal calves of all gestational ages investigated (100 to 240 days of gestation) as well as ductus arteriosus and brachiocephalic artery were active in converting arachidonic acid to these products.     

Oxidation of [Ir(η-C5Me5)(C8H4S8)] and crystal structures of [IrI(η-C5Me5)(C8H4S8)](I3) and [IrI(η-C5Me5)(C8H4S8)](I3)1/2(I7)1/2

[Ir(η⁵-C₅Me₅)(C₈H₄S₈)] (1) [ = 2-{(4,5-ethylenedithio)-1,3-dithiole-2-ylidene}-1,3-dithiole-4,5-dithionate(2−)] was reacted with iodine in dichloromethane to afford one-electron- and two-electron-oxidized species [IrI(η⁵-C₅Me₅)(C₈H₄S₈)] (2), [IrI(η⁵-C₅Me₅)(C₈H₄S₈)](I₃) (3) and [IrI(η⁵-C₅Me₅)(C₈H₄S₈)](I₅) (4). The oxidized species exhibit electrical conductivities of (1.1-5.0) × 10⁻⁶ S cm⁻¹ measured for compacted pellets at room temperature. The X-ray crystal structures of the two-electron-oxidized complexes 3 and 4 revealed the Ir-I bonds for both of them and the presence of for 3 and ions for 4 as the counter anions. They have many S-S and S-I non-bonding contacts to form two-dimensional molecular interaction sheets in the solid state.     

The arylation of [Pt2(μ-S)2(PPh3)4]

Routes to the synthesis of the mixed sulfide-phenylthiolate complex [Pt₂(μ-S)(μ-SPh)(PPh₃)₄]⁺ have been explored; reaction of [Pt₂(μ-S)₂(PPh₃)₄] with excess Ph₂IBr proceeds readily to selectively produce this complex, which was structurally characterised as its PF₆⁻ salt. Reactions of [Pt₂(μ-S)₂(PPh₃)₄] with other potent arylating reagents (1-chloro-2,4-dinitrobenzene and 1,5-difluoro-2,4-dinitrobenzene) also produce the corresponding nitroaryl-thiolate complexes [Pt₂(μ-S){μ-SC₆H₂(NO₂)₂X}(PPh₃)₄]⁺ (X = H, F). The complex [Pt₂(μ-S)(μ-SPh)(PPh₃)₄]⁺ reacts with Me₂SO₄ to produce the mixed alkyl/aryl bis-thiolate complex [Pt₂(μ-SMe)(μ-SPh)(PPh₃)₄]²⁺, but corresponding reactions with the nitroaryl-thiolate complexes are plagued by elimination of the nitroaryl group and formation of [Pt₂(μ-SMe)₂(PPh₃)₄]²⁺. [Pt₂(μ-S)(μ-SPh)(PPh₃)₄]⁺ also reacts with Ph₃PAuCl to give [Pt₂(μ-SAuPPh₃)(μ-SPh)(PPh₃)₄]²⁺.     

Influence of CH3 group of μ-N-C-S ligand on the properties of [Fe2(C4H5N2S)2(NO)4] complex

Bi-nuclear neutral sulfur-nitrosyl iron complex [Fe₂(SR)₂(NO)₄] (I) has been obtained by replacement of thiosulfate ligands in dianion [Fe₂(S₂O₃)₂(NO)₄]²⁻ by 1-methyl-imidazole-2-yl. From X-ray analysis data, the complex has centrosymmetrical dimeric structure, with the iron atoms being linked via μ-N-C-S bridge. From Mossbauer spectroscopy, isomeric shift δ_Fe is 0.180(1) mm/s and quadrupole splitting ΔE_Q is 0.928(2) mm/s at T = 290 K. By comparative studying the mass-spectra in the gaseous phase of solid samples decomposition and kinetics of NO release in 1% aqueous solutions of dimethylsulfoxide, using of the ligand with CH₃ substituent in position 1 of imidazole-2-thiol was shown to yield a more stable donor of nitrogen monoxide than earlier obtained analog with imidazole-2-thiol, [Fe₂(C₃H₃N₂S)₂(NO)₄].     

Synthesis, characterization and crystal structure of the bimetallic cyano-bridged [(η-C5H5)(PPh3)2Ru(μ-CN)Ru(PPh3)2(η-C5H5)][PF6]

The bimetallic cyano-bridged [(η⁵-C₅H₅)(PPh₃)₂Ru(μ-CN)Ru(PPh₃)₂(η⁵-C₅H₅)][PF₆] (1) was prepared by reaction of [(η⁵-C₅H₅)(PPh₃)₂RuCl] with N,N′-bis(cyanomethyl)ethylenediamine. The single crystal structure determined by X-ray diffraction showed crystallization on the triclinic P1 space group with a perfect alignment of the cyanide bridges. This accentric crystallization was explored having in view the NLO properties at the macroscopic level, determined by the Kurtz Powder technique. Besides the very low efficiency values for the second harmonic generation, the value obtained for the bimetallic complex 1 showed to be higher than one of the parent complex [(η⁵-C₅H₅)(PPh₃)₂RuCN] (2).     

Omega chain methylated analogs of PGF2α and PGE2

Our previously published prostaglandin (PG) synthesis route, in which the ω-chain is added in the penultimate step, provides facile access to a wide variety of ω-chain variant PG analogs. Each series requires only the synthesis of the appropriate methylated acylphosphonate for the Emmons' condensation. The syntheses of analogs bearing the following methylation pattern are detailed: 15-Me; 17, 17-(Me)₂; 17, 17, 20-(Me)₃; 18, 18, 20-(Me)₃; 15, 18, 18, 20-(Me)₄; and 15-Ome-18, 18, 20-(Me)₃. The well-known 16, 16-dimethyl prostaglandins have also been prepared by this sequence. The synthesis of 16, 16-tetramethylene-PG analogs is also described.     

Urinary levels of 2,3-dinor-6-oxo-PGF1α: A reliable index of the prodcution of PGI2 in the spontaneously hypertensive rat

The urinary levels of 2,3-dinor-6-oxo-PGF_1α (PGI₂-M), a major metabolite of PGI₂, are determined by the balance between the amount of PGI₂ synthesized and the extent of its further metabolic oxidation. The purpose of the present study was to determine if the urinary excretion of PGI₂-M can be used as a reliable index of the $\text{in vivo}$ production of PGI₂ in both normal Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR). This involved the exclusion of differences in metabolism between these two strains of rats. In order to do so, we monitored the urinary excretion of PGI₂-M during paired intravenous infusions of 6-oxo-PGF_1α (the stable product of the spontaneous hydrolysis of PGI₂) in conscious, unrestrained SHR and WKY rats aged 12–15 weeks, in doses ranging from 250 to 700 ng. In one experiment, PGI₂ was infused instead of 6-oxo-PGF_1α.The results of these experiments indicate that SHR and WKY rats are equal with regard to the transformation of 6-oxo-PGF_1α and PGI₂ into PGI₂-M. For both groups, there is a good correlation between the amount of 6-oxo-PGF_1α infused and the amount of PGI₂-M excreted in urine. These observations confirm the validity of using the urinary levels of 2,3-dinor-6-oxo-PGF_1α as an index of PGI₂ production in both WKY and SHR. In addition, they support the conclusions drawn from our previous studies, namely that SHR do not produce more PGI₂ than WKY rats $\text{in vivo}$, contrary to the situation prevailing $\text{in vitro}$.     

氧化苦参碱对H2O2诱导的L6成肌细胞凋亡的影响

研究氧化苦参碱对L₆大鼠成肌细胞H<>sub>2O₂凋亡的影响．采用过氧化氢损伤L₆大鼠成肌细胞的方法,建立L₆大鼠成肌细胞H₂O₂凋亡模型．使用剂量为0.3,0.15,0.75 g/L的氧化苦参碱处理细胞．应用MTT法统计存活率和流式细胞仪检测细胞周期及凋亡率,用DAPI荧光染色、HE染色以及Bax和Bcl-2抗体鉴定损伤程度,Western blot检测蛋白质差异．结果表明,H₂O₂损伤的成肌细胞存活率降低,凋亡率增加．各种剂量氧化苦参碱能提高成肌细胞的存活率,促使Bcl-2增高,Bax降低．对成肌细胞的保护程度随氧化苦参碱剂量增加而增强,在剂量为0.3 g/L时,效果显著,其次是0.15、0.75 g/L的氧化苦参碱．其生理生化机制是氧化苦参碱保护₂O₂通过NFκB信号通路造成的大鼠成肌细胞凋亡模型．结果显示,氧化苦参碱具有作为新的抗氧化药物的潜力．     

The effect of prostaglandins A2,E1,E2,15 methyl E2, 16, 16 dimethyl E2 and F2α on erythropoiesis

Prostaglandins A₂, E₁, E₂, methylated E₂s and F₂α affected erythropoiesis and/or erythropoietin (Ep) production. This action is indicated in the exhypoxic, polycythemic mouse where radioiron incorporations into RBC increased after administration of these compounds. The kidney and liver have been indicated through previous studies, to actively participate in Ep production. By the removal of one of these active sites in a murine system treated with prostaglandins it is shown that a response is reflected in Ep levels. Interference of the action of prostaglandins (PG) is altered by the removal of one of these target sites of Ep production. The erythropoietic responses elicited by PGA₂, E₁, and perhaps the methylated PGE₂s act through the liver whereas PGE₂ may operate through a renal pathway for its response. PGF_2α reveals no effect on erythropoietic activity and is no different than that observed for vehicle-treated controls. The prostaglandins tested appear to act primarily through the kidney or liver but the possibility exists that some yet undetermined organ site may also be involved.     

Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1α in rat brain

Thromboxane B₂ and 6-keto-PGF_1α (6KPGF_1α), the major stable metabolites of thromboxane and prostacyclin, are present in the CNS, where they appear to be mainly produced within and/or acting upon the vascular district. Their concentrations are of few pg/mg protein in rat brain cortex of animals sacrificed by microwave (MW) radiation, procedure which inactivates tissue enzymes and allows the determination of endogenous “basal” levels of eicosanoids. Levels of 6KPGF_1α and especially those of TxB₂ increase several fold over the basal values in brain cortex of animals sacrificed by decapitation followed by a few minute interval before analysis (post-decapitation ischemia, PDI). Pretreatment of animals with the vasoactive drug papaverine, resulted in elevation of brain basal levels of 6KPGF_1α and with the carbochromene derivartive AD₆ in reduction of basal levels of TxB₂, whereas the calcium antagonist nifedipine and dipyridamole did not modify basal levels of the two eicosanoids. Treatments with papaverine and AD₆ reduced the accumulation of TxB₂ and enhanced that of 6KPGF_1α occurring after PDI, to different extents, both resulting, however, in reduction of the TxB₂/6KPGF_1α ratio. Nifedipine instead, decreased the release of both eicosanoids and resulted in elevation of the TxB₂/6KPGF_1α ratio, whereas dipyridamole had no effect. In conclusion, the evaluation of the overall effects of drug treatments on the TxB₂/6KPGF_1α ratio in cerebral tissue, provided useful informations on the pharmacological modulation of vascular eicosanoids in this district.     

D and D Nuclear magnetic resonance of new silver(I) complexes with achiral and chiral bases as ligands: Crystal structure of [Ag{(S)-(6-CH3)C5H3N-CHN-C*H(α-CH3)C6H5}(PPh3)2](O3SCF3)

Treatment of equimolar amounts of substituted aniline or amine with substituted benzaldehyde leads to the corresponding achiral or chiral Schiff bases (L). The reaction of the bases with [Ag(O₃SCF₃)(PPh₃)] leads to the preparation of three or four coordinated cationic complexes, [Ag(k¹-L)(PPh₃)_n]⁺ (n = 1 or 2) which have been characterized by IR, ¹D and ²D NMR spectroscopy. The crystal structure of [Ag{(S)-(6-CH₃)C₅H₃N-CHN-C*H(α-CH₃)C₆H₅}(PPh₃)₂](O₃SCF₃) is reported.     

Thallium(III) complexes of the metalloligands [Pt2(μ-S)2(PPh3)4] and [Pt2(μ-Se)2(PPh3)4]

Reactions of [Pt₂(μ-S)₂(PPh₃)₄] with the diarylthallium(III) bromides Ar₂TlBr [Ar = Ph and p-ClC₆H₄] in methanol gave good yields of the thallium(III) adducts [Pt₂(μ-S)₂(PPh₃)₄TlAr₂]⁺, isolated as their salts. The corresponding selenide complex [Pt₂(μ-Se)₂(PPh₃)₄TlPh₂]BPh₄ was similarly synthesised from [Pt₂(μ-Se)₂(PPh₃)₄], Ph₂TlBr and NaBPh₄. The reaction of [Pt₂(μ-S)₂(PPh₃)₄] with PhTlBr₂ gave [Pt₂(μ-S)₂(PPh₃)₄TlBrPh]⁺, while reaction with TlBr₃ gave the dibromothallium(III) adduct [Pt₂(μ-S)₂(PPh₃)₄TlBr₂]⁺[TlBr₄]⁻. The latter complex is a rare example of a thallium(III) dihalide complex stabilised solely by sulfur donor ligands. X-ray crystal structure determinations on the complexes [Pt₂(μ-S)₂(PPh₃)₄TlPh₂]BPh₄, [Pt₂(μ-S)₂(PPh₃)₄TlBrPh]BPh₄ and [Pt₂(μ-S)₂(PPh₃)₄TlBr₂][TlBr₄] reveal a greater interaction between the thallium(III) centre and the two sulfide ligands on stepwise replacement of Ph by Br, as indicated by shorter Tl-S and Pt?Tl distances, and an increasing S-Tl-S bond angle. Investigations of the ESI MS fragmentation behaviour of the thallium(III) complexes are reported.